Bayer to seek approval for new hemophilia drug by year-end

FRANKFURT (Reuters) - German drugmaker Bayer AG will file for regulatory approval of its experimental hemophilia drug Bay 81-8973 by the end of the year, it said on Tuesday. (Reporting by Ludwig Burger; Editing by Maria Sheahan)

via Health News Headlines - Yahoo News Read More Here..

For a Free Step By Step Guide for Dating Dos and Don'ts check http://end2endwebs.com

Lake forest health and fitness http://ift.tt/1rRGRl5